Alphagan P

Known as: alphagan-p 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2016
0120002016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
UNLABELLED Conventional eye drops quickly move away from the surface of the eye; as a result, ocular bioavailability is very… (More)
Is this relevant?
2015
2015
Topical drug administration to the eye is limited by low drug bioavailability due to its rapid clearance from the preocular… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2014
Review
2014
  • 2014
Background: The first goal of medical therapy in glaucoma is to reduce intraocular pressure (IOP), and the fixed-combination… (More)
  • table 1
Is this relevant?
Review
2008
Review
2008
BACKGROUND The use of brimonidine to lower intraocular pressure has been the subject of considerable investigation. Variations of… (More)
Is this relevant?
2003
2003
The tolerability of brimonidine tartrate 0.15%--referred to as bromonidine-Purite 0.15% in this study--was compared with… (More)
Is this relevant?
2000
2000
PURPOSE To provide patients and health care providers with calculated yearly costs of topical glaucoma medications. DESIGN… (More)
  • table 2
  • table 3
  • table 3
Is this relevant?